Depression - Major Depressive Disorder Clinical Trials

66 recruitingLast updated: June 17, 2026

There are 66 actively recruiting depression - major depressive disorder clinical trials across 24 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4, Phase 3. Top locations include Charleston, South Carolina, United States, Beijing, Beijing Municipality, China, Hong Kong, Hong Kong. Updated daily from ClinicalTrials.gov.


Depression - Major Depressive Disorder Trials at a Glance

66 actively recruiting trials for depression - major depressive disorder are listed on ClinicalTrialsFinder across 6 cities in 24 countries. The largest study group is Not Applicable with 43 trials, with the heaviest enrollment activity in Charleston, Beijing, and Hong Kong. Lead sponsors running depression - major depressive disorder studies include Medical University of South Carolina, Massachusetts General Hospital, and Peking University.

Browse depression - major depressive disorder trials by phase

Treatments under study

About Depression - Major Depressive Disorder Clinical Trials

Looking for clinical trials for Depression - Major Depressive Disorder? There are currently 66 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Depression - Major Depressive Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Depression - Major Depressive Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 66 trials

Recruiting
Phase 3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

DepressionDepression - Major Depressive DisorderDepression in Adults+3 more
Cybin IRL Limited330 enrolled67 locationsNCT06793397
Recruiting
Not Applicable

Enhancing Slow Wave Sleep in Depression

Depression - Major Depressive Disorder
Wake Forest University Health Sciences12 enrolled1 locationNCT07143838
Recruiting
Not Applicable

Analgesic Efficacy of Multisite rTMS in Fibromyalgia Patients

Depression - Major Depressive DisorderChronic PainFibromyalgia
Hospital Ambroise Paré Paris36 enrolled1 locationNCT07642882
Recruiting
Phase 2

Mindfulness-based Psilocybin Therapy for PTSD

Depression - Major Depressive DisorderPost Traumatic Stress Disorder
Anthony P King30 enrolled1 locationNCT07104916
Recruiting
Not Applicable

Effects of Concurrent and Consecutive Repetitive Transcranial Magnetic Stimulation (rTMS) and Cognitive Bias Modification (CBM)

Depression - Major Depressive Disorder
The University of Hong Kong180 enrolled1 locationNCT07636694
Recruiting
Not Applicable

Preliminary Efficacy Trial of a Digital Intervention for Depression and Cannabis Use

Depression - Major Depressive DisorderMental DisorderCannabis Use Disorder
Massachusetts General Hospital80 enrolled1 locationNCT06878859
Recruiting
Not Applicable

Flumazenil for Benzodiazepine Reversal in Electroconvulsive Therapy

Autobiographical MemoryDepression - Major Depressive DisorderTreatment Outcome+6 more
Anders Jørgensen145 enrolled1 locationNCT07619092
Recruiting
Not Applicable

Group-based ACT for Psychological Distress of Young People

Anxiety DepressionAnxietyDepression - Major Depressive Disorder+1 more
Sorlandet Hospital HF212 enrolled2 locationsNCT07617467
Recruiting
Not Applicable

Feasibility, Safety, and Preliminary Clinical Efficacy of Magnetic Resonance Imaging-guided Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression: A Randomized, Double-Blind, Controlled Pilot Study

Depression - Major Depressive Disorder
First Affiliated Hospital of Chongqing Medical University45 enrolled1 locationNCT07185438
Recruiting
Phase 2

Stratified Pharmacological Approaches for Regulating Circuit-Level Effects

Depression - Major Depressive Disorder
Stanford University60 enrolled1 locationNCT07022405
Recruiting
Not Applicable

AI-Guided CBT for Depression and Anxiety

Depression - Major Depressive DisorderAnxiety Disorders
Aleksandra Stojanovic120 enrolled1 locationNCT07576686
Recruiting
Not Applicable

Feasibility and Acceptability of an E-learning Dialectical Behavior Therapy Skills Course

DepressionStressAnxiety+2 more
University of Windsor40 enrolled1 locationNCT07088939
Recruiting
Phase 1Phase 2

Personalized Ultrasonic Brain Stimulation for Depression (R61)

Depression - Major Depressive DisorderMajor Depressive EpisodeTreatment-Resistant Major Depressive Disorder
Brian Mickey30 enrolled1 locationNCT06902298
Recruiting
Phase 1Phase 2

Psilocybin to Treat Depression in Spinal Cord Injury

Depression - Major Depressive DisorderSpinal Cord InjuryVeteran
James J. Peters Veterans Affairs Medical Center30 enrolled1 locationNCT07251491
Recruiting
Phase 1Phase 2

Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains

Depression - Major Depressive Disorder
University of Cincinnati67 enrolled1 locationNCT06795451
Recruiting
Not Applicable

Brief Trial of ACT-i for Adults With Chronic Insomnia

Chronic InsomniaAnxietyDepression - Major Depressive Disorder
Babes-Bolyai University76 enrolled1 locationNCT07048600
Recruiting
Not Applicable

Integrating Digital Phenotypes and AI-Driven Cognitive-Behavioral Therapy: Advancing Precision Medicine in Depression Through Digital Medicine

Depression - Major Depressive Disorder
National Science and Technology Council, Taiwan100 enrolled1 locationNCT07500714
Recruiting
Not Applicable

IMST for Dementia Risk Reduction

Sleep QualityCognitive FunctionBlood Pressure+4 more
Florida State University30 enrolled1 locationNCT07349706
Recruiting
Not Applicable

Nutritional Intervention for College Students With Depression

Depression - Major Depressive Disorder
University of California, San Diego30 enrolled1 locationNCT07490782
Recruiting

Brain Imaging of Cognition Inn Schizophrenia and Depression

Depression - Major Depressive DisorderSchizophrenia / Schizoaffective Disorder
The Royal Ottawa Mental Health Centre90 enrolled1 locationNCT04159662